All the Active Ingredient Drugs
Meningococcal Vaccine. Meningococcus B, multicomponent vaccine (subfamily A1,2,3) 60 mcg, Meningococcus B, multicomponent vaccine (subfamily B1,2,3) 60 mcg. VIAL (susp. for IM inj.): 1,5,10 × 0.5ml.
Primary series: 2 doses (0.5 ml each) admin. at a 6 mnth. interval.
3 doses: 2 doses (0.5 ml each) adm. at least 1 mnth. apart, followed by a 3rd dose at least 4 mnths. after the 2nd dose.
Booster dose: A booster dose should be consid. follow. either dosing regimen for individuals at continued risk of invas. meningococcal dis.
Other ped. population: not indicated for child. under 10 yrs. old.
Active immunisation of individ. 10 yrs. and older to prevent invas. meningococ. dis. caused by Neisseria meningitidis serogroup B.
The use of this vaccine should be in accordance with official recommendations.